A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma

European Journal of Haematology

Volumn 82, Issue 3, 2009, Pages 231-234

  Dasanu, Constantin A ^a,c   Alexandrescu, Doru T ^b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Gothic Park   (United States)

Author keywords

Aplastic anemia; Autoimmunity; Immunomodulatory drugs; Lenalidomide; Stem cells

Indexed keywords

BORTEZOMIB; DEXAMETHASONE; DOXORUBICIN; LENALIDOMIDE; VINCRISTINE;

ADULT; ANAMNESIS; APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG WITHDRAWAL; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PRIORITY JOURNAL;

ANEMIA, APLASTIC; ANTINEOPLASTIC AGENTS; BIOPSY; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; THALIDOMIDE;

EID: 58849084133     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01176.x     Document Type: Article

References (8)

1. Knight R. IMiDs: a novel class of immunomodulators. Semin Oncol 2005 32 : S24 30.
2. Kumar S, Dispenzieri A, Lacy MQ, et al. Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma. Leukemia 2007 21 : 2035 42.
3. Melchert M, List A. The thalidomide saga. Int J Biochem Cell Biol 2007 39 : 1489 99.
4. Chanan-Khan AA, Cheson BD. Lenalidomide for the treatment of B-cell malignancies. J Clin Oncol 2008 26 : 1544 52.
5. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006 108 : 2509 19.
6. Darabi K, Kantamnei S, Wiernik PH. Lenalidomide-induced warm autoimmune hemolytic anemia. J Clin Oncol 2006 24 : e59.
7. Menon S, Habermann T, Witzig T. Lenalidomide-associated hypothyroidism. Leuk Lymphoma 2007 48 : 2465 7.
8. Deng A, Harvey V, Sina B, et al. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol 2006 142 : 198 202.